Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis

Breast Cancer Research and Treatment

Volumn 46, Issue 2-3, 1997, Pages 181-189

  Moon, Richard C ^a   Constantinou, Andreas I ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Breast cancer; Carcinogenesis; Carotenoids; Chemoprevention; Differentiation; In vivo; Retinoids

Indexed keywords

CAROTENOID; DIMETHYLBENZ[A]ANTHRACENE; FENRETINIDE; METHYLNITROSOUREA; RETINOID; RETINOL ACETATE; TAMOXIFEN;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RECURRENCE; CHEMOPROPHYLAXIS; DIETARY INTAKE; FEMALE; LATENT PERIOD; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TISSUE LEVEL;

ANIMALS; ANTICARCINOGENIC AGENTS; CAROTENOIDS; DISEASE MODELS, ANIMAL; FEMALE; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RATS; RETINOIDS;

EID: 0031460554     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005995925246     Document Type: Review

References (46)

1. Watternberg LW: Chemoprophylaxis of carcinogenesis: A review. Cancer Res 26:1520-1526, 1966
2. Sporn MB, Dunlop NM, Newton DL, Smith JM: Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35:1332-1338, 1976
3. Sporn MB, Newton DL: Chemoprevention of cancer with retinoids. Fed Proc 38:2528-2534, 1979
4. Lasnitzki I: Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analogs. Br J Cancer 34:239-248, 1976
5. Chopra DP, Wilkoff CJ: Inhibition and reversal by 13-retinoic acid of hyperplasia induced in cultured mouse prostate tissue by 3-methylcholanthrene or N-methyl-N-nitrosoguanidine. J Natl Cancer Inst 56:583-589, 1976
6. Harisiadis L, Miller RC, Hall EJ, Borek C: A vitamin A analogue inhibits radiation-induced oncogene transformation. Nature 274:486-487, 1978
7. Merriman RL, Bertram JS: Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H/IOTI/2 CL8 cells. Cancer Res 39:1661-1666, 1979
8. Todaro GJ, DeLarco JE: Growth factors produced by sarcoma virus transformed cells. Cancer Res 38: 4147-4154, 1978
9. Moon RC: Comparative aspects of carotenoids and retinoids as chemopreventive agents for cancer. J Nutr 119:127-134, 1989
10. Clamon GH, Sporn MB, Smith JM, Saffiotti U: Alpha and beta retinyl acetate reverse metaplasia of vitamin A deficiency in hamster trachea in organ culture. Nature (London) 250:64-66, 1974
11. Strickland S, Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393-403, 1978
12. Strickland S, Sawey M: Studies on the effect of retinoids on the differentiation of teratocarcinoma cells in vitro and in vivo. Dev Biol 78:76-85, 1980
13. Napoli JL: The biogenesis of retinoic acid: A physiologically significant promoter of differentiation: In: Dawson MI, Okamura WH (eds) Chemistry and Biology of Synthetic Retinoids. CRC Press, Boca Raton FL, 1989, pp 229-249
14. Breitman T, Selonick S, Collins S: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936-2940, 1980
15. Strickland S, Breitman TR, Frickel F, Nurenbach A, Hadicke E, Sporn MB: Structure-activity relationships of a new series of retinoidal benzoic derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Cancer Res 43:5268-5272, 1983
16. Sporn MB, Clamon GH, Dunlop NM, Newton DL, Smith JM, Saffiotti U: Activity of vitamin A analogs in cell cultures of mouse epidermis and organ cultures of hamster trachea. Nature 253:47-50, 1975
17. Dickens MS, Custer RP, Sorof S: Retinoid prevents mammary gland transformation by carcinogenic hydrocarbon in whole-organ culture. Proc Natl Acad Sci USA 76:5891-5895, 1979
18. Mehta RG, Cerny WL, Moon RC: Retinoids inhibit prolactin-induced development of the mammary gland in vitro. Carcinogenesis 4:23-26, 1983
19. Moon RC: Vitamin A, retinoids and breast cancer. In: Weisburger EK (ed) Diet and Breast Cancer. Plenum Press, New York, 1994, pp 101-107
20. Gullino PM, Pettigrew HM, Grantham FH: N-nitrosomethylurea as a mammary gland carcinogen in rats. J Natl Cancer Inst 54:401-414, 1975
21. McCormick DL, Adamowski CB, Fiks A, Moon RC: Lifetime dose response relationship for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res 41:1690-1694, 1981
22. Moon RC, Grubbs CJ, Sporn MB: Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate. Cancer Res 36:2626-2630, 1976
23. Schmahl D, Kruger C, Preissler P: Versuche zur Krebsprophylaxe mit vitamin A. Arzneim Forsch 22: 946-949, 1972
24. Grubbs CJ, Moon RC, Squire RA, Farrow GM, Stinson SF, Goodman DG, Brown CC, Sporn MB: 13-cis-retinoic acid: inhibition of bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Science 198:743-744, 1977
25. Janss DH Moon RC, Irving CC: The binding of 7,12-dimethylbenz(a)anthracene to mammary parenchyma DNA and protein in vivo. Cancer Res 32:254-258, 1972
26. Moon RC, Grubbs CJ, Sporn MB, Goodman DG: Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosourea. Nature 267:620-621, 1977
27. Moon RC, Thompson HJ, Becci PJ, Grubbs CJ, Gander RJ, Newton JM, Smith SR, Philips WR, Henderson WR, Mullen LT, Brown CC, Sporn MB: N-(4-hydroxyphenyl) retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res 39:1339-1346, 1979
28. Hultin TA, May CM, Moon RC: N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice. Drug Metab Dispos 14:714-717, 1986
29. Mehta RG, Hultin TA, Moon RC: Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland organ culture. Biochem J 256:579-584, 1988
30. Mehta RG, Hawthorne M, Moon RC, Formelli F, Costa A: Distribution of fenretinide in the mammary gland of breast cancer patients. Eur J Cancer 27:138-141, 1991
31. Hartmann HR, Bollag W: The effects of arotinoids on rat mammary carcinogenesis. Cancer Chemother Pharmacol 15:141-143, 1985
32. Moon RC, Mehta RG: Cancer chemoprevention by retinoids: animal models. Meth Enzymol 190:395-406, 1990
33. Maiorana A, Gullino P: Effect of retinyl acetate on the incidence of mammary carcinomas and hepatomas in mice. J Natl Cancer Inst 64:655-663, 1980
34. Welsch CW, Goodrich-Smith M, Brown CC, Crowe N: Enhancement by retinyl acetate of hormone induced mammary tumorigenesis in female GR A mice. J Natl Cancer Inst 67:935-938, 1981
35. Grubbs CJ, Eto IJ, Hardin JM, Whitaker LM: Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors. Anticancer Res 10:661-666, 1990
36. McCormick DL, Moon RC: Influence of delayed administration of retinyl acetate on mammary carcinogenesis. Cancer Res 42:2639-2643, 1982
37. Moon RC, Pritchard JF, Mehta RG, Moides CT, Thoma CF, Dinger NM: Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. Carcinogenesis 10:1645-1649, 1989
38. McCormick DL, Sowell ZS, Thompson CA, Moon RC: Inhibition by retinoid and ovariectomy of additional primary malignancies in rats following surgical removal of the first mammary cancer. Cancer 51:594-599, 1983
39. Veronesi U, Costa A: Chemoprevention of contralateral breast cancer with synthetic retinoid fenretinide. Proceedings Of The First International Chemoprevention Workshop. Cancer Invest 6:55-57, 1988
40. Costa A, Sacchini V, Decensi A: Retinoids and tamoxifen in breast cancer chemoprevention. Int J Clin Lab Res 23:53-55, 1993
41. McCormick DL, Mehta RG, Thompson CA, Dinger N, Caldwell JA, Moon RC: Enhanced inhibition of mammary carcinogenesis by combination N-(4-hydroxyphenyl) retinamide and ovariectomy. Cancer Res 42:509-512, 1982
42. Ratko TA, Detrisac CJ, Dinger NM, Thomas CT, Kelloff GJ, Moon RC: Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res 49:4472-4476, 1989
43. Som S, Chatterjee M, Banerjee MR: Beta-carotene inhibition of 7,12-dimethylbenz[a]anthracene-induced transformation of murine mammary cells in vitro. Carcinogenesis 5:937-940, 1984
44. Grubbs CJ, Eto I, Juliana MM, Whitaker LM: Effect of canthaxanthin on chemically induced mammary carcinogenesis. Oncology 48:239-245, 1991
45. Nagasawa H, Mitamura T, Sakamoto S, Yamamoto K: Effects of lycopene on spontaneous mammary tumor development in SHN virgin mice. Anticancer Res 7:195-198, 1996
46. Ingram D: Diet and subsequent survival in women with breast cancer. Br J Cancer 69:592-595, 1994